Lv41
428 积分 2025-03-02 加入
Development of Glypican 3–Targeting Antibody–Drug Conjugates for Hepatocellular Carcinoma Therapy
4小时前
待确认
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers
1个月前
已完结
Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo
1个月前
已完结
Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo
1个月前
已关闭
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
3个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
3个月前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
3个月前
已完结
A GPC1-targeted and gemcitabine-loaded Biocompatible Nanoplatform for Pancreatic Cancer Multimodal Imaging and Therapy
4个月前
已完结
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein
4个月前
已完结
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer
4个月前
已完结